Literature DB >> 11922676

The crystal structure of the sorcin calcium binding domain provides a model of Ca2+-dependent processes in the full-length protein.

Andrea Ilari1, Kenneth A Johnson, Vassilios Nastopoulos, Daniela Verzili, Carlotta Zamparelli, Gianni Colotti, Demetrius Tsernoglou, Emilia Chiancone.   

Abstract

Sorcin is a 21.6 kDa calcium binding protein, expressed in a number of mammalian tissues that belongs to the small, recently identified penta-EF-hand (PEF) family. Like all members of this family, sorcin undergoes a Ca2+-dependent translocation from cytosol to membranes where it binds to target proteins. For sorcin, the targets differ in different tissues, indicating that it takes part in a number of Ca2+-regulated processes. The sorcin monomer is organized in two domains like in all PEF proteins: a flexible, hydrophobic, glycine-rich N-terminal region and a calcium binding C-terminal domain. In vitro, the PEF proteins are dimeric in their Ca2+-free form, but have a marked tendency to precipitate when bound to calcium. Stabilization of the dimeric structure is achieved by pairing of the uneven EF-hand, EF5. Sorcin can also form tetramers at acid pH. The sorcin calcium binding domain (SCBD, residues 33-198) expressed in Escherichia coli was crystallized in the Ca2+-free form. The structure was solved by molecular replacement and was refined to 2.2 A with a crystallographic R-factor of 22.4 %. Interestingly, the asymmetric unit contains two dimers. The structure of the SCBD leads to a model that explains the solution properties and describes the Ca2+-induced conformational changes. Phosphorylation studies show that the N-terminal domain hinders phosphorylation of SCBD, i.e. the rate of phosphorylation increased twofold in the absence of the N-terminal region. In addition, previous fluorescence studies indicated that hydrophobic residues are exposed to solvent upon Ca2+ binding to full-length sorcin. The model accounts for these data by proposing that Ca2+ binding weakens the interactions between the two domains and leads to their reorientation, which exposes hydrophobic regions facilitating the Ca2+-dependent binding to target proteins at or near membranes. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922676     DOI: 10.1006/jmbi.2002.5417

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

Review 1.  Sorcin, a potential therapeutic target for reversing multidrug resistance in cancer.

Authors:  Bei-Bei Zheng; Peng Zhang; Wei-Wei Jia; Lu-Gang Yu; Xiu-Li Guo
Journal:  J Physiol Biochem       Date:  2012-06       Impact factor: 4.158

2.  Sorcin ablation plus β-adrenergic stimulation generate an arrhythmogenic substrate in mouse ventricular myocytes.

Authors:  Xi Chen; Craig Weber; Emily T Farrell; Francisco J Alvarado; Yan-Ting Zhao; Ana M Gómez; Héctor H Valdivia
Journal:  J Mol Cell Cardiol       Date:  2017-11-22       Impact factor: 5.000

3.  Molecular basis for defect in Alix-binding by alternatively spliced isoform of ALG-2 (ALG-2DeltaGF122) and structural roles of F122 in target recognition.

Authors:  Tatsutoshi Inuzuka; Hironori Suzuki; Masato Kawasaki; Hideki Shibata; Soichi Wakatsuki; Masatoshi Maki
Journal:  BMC Struct Biol       Date:  2010-08-06

4.  Activation of the cardiac Na(+)-Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains.

Authors:  Carlotta Zamparelli; Niall Macquaide; Gianni Colotti; Daniela Verzili; Tim Seidler; Godfrey L Smith; Emilia Chiancone
Journal:  J Mol Cell Cardiol       Date:  2010-03-15       Impact factor: 5.000

5.  Glucose-induced nuclear shuttling of ChREBP is mediated by sorcin and Ca(2+) ions in pancreatic β-cells.

Authors:  Nafeesa A Noordeen; Gargi Meur; Guy A Rutter; Isabelle Leclerc
Journal:  Diabetes       Date:  2012-02-14       Impact factor: 9.461

6.  Sorcin Links Pancreatic β-Cell Lipotoxicity to ER Ca2+ Stores.

Authors:  Alice Marmugi; Julia Parnis; Xi Chen; LeAnne Carmichael; Julie Hardy; Naila Mannan; Piero Marchetti; Lorenzo Piemonti; Domenico Bosco; Paul Johnson; James A M Shapiro; Céline Cruciani-Guglielmacci; Christophe Magnan; Mark Ibberson; Bernard Thorens; Héctor H Valdivia; Guy A Rutter; Isabelle Leclerc
Journal:  Diabetes       Date:  2016-01-28       Impact factor: 9.461

7.  Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity.

Authors:  Maria Berrocal; Lucia Saez; Ana M Mata
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

8.  Sorcin links calcium signaling to vesicle trafficking, regulates Polo-like kinase 1 and is necessary for mitosis.

Authors:  Vasiliki S Lalioti; Andrea Ilari; David J O'Connell; Elena Poser; Ignacio V Sandoval; Gianni Colotti
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

9.  Structural basis of Sorcin-mediated calcium-dependent signal transduction.

Authors:  Andrea Ilari; Annarita Fiorillo; Elena Poser; Vasiliki S Lalioti; Gustav N Sundell; Ylva Ivarsson; Ilaria Genovese; Gianni Colotti
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

10.  Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.

Authors:  Ilaria Genovese; Annarita Fiorillo; Andrea Ilari; Silvia Masciarelli; Francesco Fazi; Gianni Colotti
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.